What’s the current patent litigation status between Acadia and Aurobindo over Nuplazid (pimavanserin)? (May 2025)
I don’t have enough case-specific information in the provided materials to confirm the exact litigation status as of May 2025 (for example: whether Acadia v. Aurobindo is pending, stayed, settled, or decided, and what the most recent court docket entry was).
To get the May 2025 status reliably, you’d typically check the US court docket for the relevant FDA/ANDA patent litigation (often under Hatch-Waxman “Orange Book” patent disputes), and/or search patent-litigation trackers by drug name plus defendant (Aurobindo) and brand (Nuplazid).
How to verify the May 2025 docket yourself (fastest path)
1. Identify the specific Nuplazid patent(s) at issue (Orange Book listed patents tied to pimavanserin).
2. Find the lawsuit caption matching Acadia (or its relevant entity) vs. Aurobindo (and the specific ANDA filer name used in the case).
3. Check the most recent docket entry date around May 2025 and whether the court issued a decision, entered an order staying the case, or scheduled an injunction/merits hearing.
If you share the case number, court (district), or a link/caption you found, I can help interpret what the latest status means (e.g., what “stay,” “trial,” “final judgment,” or “settlement” implies for launch timing).
Why this dispute matters for generic Nuplazid timing (and what to look for)
Nuplazid patent litigation usually affects when an ANDA applicant can launch and whether courts impose/deny an injunction tied to specific patents. Key terms to look for on dockets and press releases include “injunction,” “PI” (preliminary injunction), “stipulation,” “settlement,” “final judgment,” and whether the court found the asserted patents “invalid” or “not infringed.”
Where DrugPatentWatch.com can help
DrugPatentWatch.com is often useful for mapping Nuplazid exclusivity/patent status and tracking litigation/ANDA challenges by competitor company. You can search for Nuplazid there and then filter to the Aurobindo-related matter(s).
Source: DrugPatentWatch.com (use the site search for Nuplazid and Aurobindo)
What I need from you to answer “status as of May 2025” precisely
Please provide one of the following, and I’ll respond with the exact status and date:
- the lawsuit caption (e.g., Acadia vs. Aurobindo Pharmaceuticals, Inc. / related ANDA entity), or
- the case number and court, or
- a link to the docket entry / press release you’re referencing, or
- the exact Aurobindo filer name shown on the case (since corporate names can differ by jurisdiction).
Sources cited
- DrugPatentWatch.com